Clinical Trials Sponsored by TcLand Expression S.A.

Total 22 results

TcLand Expression S.A.
European Commission

Terminated

RABIOPRED - a Validation Study of Theranostic Test to PREDict Treatment Response of Anti-TNFα BIologicals in Rheumatoid Arthritis (RABIOPRED)

RheumatoId Arthritis

France, Netherlands, Turkey, Czechia, Israel
TcLand Expression S.A.
Premier Research Group plc; Theradis pharma; Medpharmgene, Inc.

Terminated

Validation Study of RA-INF-Dx, a Multigene Molecular Test Used to Predict Non-Response to INfliximab Therapy (PRINT)

Rheumatoid Arthritis

Canada, France, Hungary, Italy, Lithuania, Romania, Slovakia, Spain
Hospital Clinic of Barcelona
Fondo de Investigacion Sanitaria; European Commission; TcLand Expression S.A.

Unknown

Assessment Of the Safety and Benefit of Prospective Immunosuppressive Drug Withdrawal in Liver Transplantation and Prediction of Operational Tolerance

Liver Transplantation

Spain
Jagiellonian University
National Center for Research and Development, Poland; Bioscience, S.A.; Braster...

Unknown

Effectiveness of Liquid Crystal Contact Thermography in Detecting Pathological Changes in Female Breasts

Breast Cancer

Poland
Read-Gene S.A.
National Center for Research and Development, Poland; IQ Pharma S.A.; West Pomeranian... and other collaborators

Active, not recruiting

Prevention of Female Cancers by Optimization of Selenium Levels in the Organism. (SELINA)

Breast Neoplasms

Poland
Tulane University School of Medicine
National Alliance for Research on Schizophrenia and Depression

Completed

D-cycloserine Adjunctive Treatment for Posttraumatic Stress Disorder (PTSD) in Adolescents

PTSD | Posttraumatic Stress Disorder

United States
OASIS Diagnostics S.A.
National Center for Research and Development, Poland

Completed

Detection of Obstetric Anal Sphincter Injuries With ONIRY Device

Obstetric Complication | Delivery Complication | Obstetric Anal Sphincter Injury

Spain, Czechia, Poland, Slovakia
IBSS Biomed S.A.
Ministry of Science and Higher Education, Poland

Completed

Effects of Oral Probiotic Supplementation on the Clinical Status of Very-low-birth-weight Preterm Neonates.

Necrotizing Enterocolitis | Infant, Very Low Birth Weight | Late Onset Neonatal Sepsis
Celon Pharma SA
National Center for Research and Development, Poland

Recruiting

Efficacy, Safety and Pharmacokinetic Study of CPL500036 in Patients With Levodopa Induced Dyskinesia

Parkinson Disease | Dyskinesia, Medication-Induced

Poland, Ukraine
Celon Pharma SA
National Center for Research and Development, Poland

Recruiting

Efficacy, Safety and Pharmacokinetics Study of CPL500036 (PDE10A Inhibitor) in Patients With Schizophrenia

Schizophrenia

Hungary, Poland, Ukraine
University of Warmia and Mazury
Zaklady Farmaceutyczne Polpharma SA / Poland

Active, not recruiting

Arterial Hypertension in Men in the Warmia and Masuria Region (ProM)

Arterial Hypertension

Poland
Celon Pharma SA
National Center for Research and Development, Poland

Recruiting

Efficacy and Safety Study Comparing CPL409116 to Placebo in Participants With Active Rheumatoid Arthritis

Rheumatoid Arthritis

Poland, Ukraine
Celon Pharma SA
National Center for Research and Development, Poland

Recruiting

Efficacy, Safety and Pharmacokinetics Study of CPL207280 After 2-weeks Administration in Subjects With Type 2 Diabetes

Type 2 Diabetes

Poland
Celon Pharma SA
National Center for Research and Development, Poland

Completed

Efficacy, Safety and Pharmacokinetic Study of Inhaled Esketamine in Treatment-resistant Depression

Major Depressive Disorder

Poland
Celon Pharma SA
National Center for Research and Development, Poland

Completed

Safety and Pharmacokinetics Study of CPL500036 Compound in Healthy Volunteers

Healthy Volunteers

Poland
Celon Pharma SA
National Center for Research and Development, Poland

Recruiting

Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies

Sarcoma | Gastric Cancer | Cholangiocarcinoma | Bladder Cancer | Endometrial Cancer | Squamous Non-small Cell Lung Cancer | Other Solid Tumours

Poland
Celon Pharma SA
National Center for Research and Development, Poland

Completed

Safety and Pharmacokinetics of JAK/ROCK Inhibitor in Healthy Volunteers

Healthy

Poland
Celon Pharma SA
National Center for Research and Development, Poland

Completed

Safety and Pharmacokinetics Study of CPL207280 Compound in Healthy Volunteers.

Healthy Volunteers

Poland
Celon Pharma SA
National Center for Research and Development, Poland

Completed

Efficacy, Safety and Pharmacokinetic Study of Inhaled Esketamine in Treatment-resistant Bipolar Depression

Bipolar Depression

Poland
Celon Pharma SA
National Center for Research and Development, Poland

Completed

Safety and Pharmacokinetic Study of Inhaled Esketamine in Healthy Volunteers

Healthy Volunteers

Poland
Barnes Retina Institute
Massachusetts Eye and Ear Infirmary; Long Island Vitreoretinal Consultants; Illinois... and other collaborators

Completed

Bevacizumab Versus Ranibizumab in Treatment of Macular Edema From Vein Occlusion (CRAVE)

Macular Edema | Retinal Vein Occlusion

United States
Merck KGaA, Darmstadt, Germany
Merck Serono GmbH, Germany; Merck B.V., Netherlands; Merck A.E., Greece; Merck... and other collaborators

Completed

PERgoveriS In Stratified Treatment for Assisted Reproductive Technique (PERSIST)

Assisted Reproductive Techniques | Reproductive Technology, Assisted

Italy, Russian Federation, United Kingdom, Germany, Poland, Finland, Slovakia, Netherlands, Denmark, France, Greece

Clinical Trials Sponsored by TcLand Expression S.A.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Liberia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations